Vitamin B6 inhibits activity of

Helicobacter pylori / drug effects Anti-Bacterial Agents / pharmacology Microbial Sensitivity Tests Vitamin B 6 / pharmacology Structure-Activity Relationship Adenylosuccinate Synthase / metabolism Molecular Structure Dose-Response Relationship, Drug Enzyme Inhibitors / pharmacology Drug Resistance, Bacterial / drug effects Pyridoxal Phosphate / pharmacology Models, Molecular
Adenylosuccinate synthetase Helicobacter pylori X-ray structure antimicrobial activity vitamin B6

Journal

Journal of enzyme inhibition and medicinal chemistry
ISSN: 1475-6374
Titre abrégé: J Enzyme Inhib Med Chem
Pays: England
ID NLM: 101150203

Informations de publication

Date de publication:
Dec 2024
Historique:
medline: 16 8 2024
pubmed: 16 8 2024
entrez: 16 8 2024
Statut: ppublish

Résumé

The current therapies against gastric pathogen

Identifiants

DOI: 10.1080/14756366.2024.2372734 PMID: 39149761
pubmed: 39149761
doi: 10.1080/14756366.2024.2372734
doi:

Substances chimiques

Anti-Bacterial Agents 0
Vitamin B 6 8059-24-3
Adenylosuccinate Synthase EC 6.3.4.4
Enzyme Inhibitors 0
Pyridoxal Phosphate 5V5IOJ8338

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2372734

Auteurs

Marta Ilona Wojtyś (MI)

Division of Biophysics, Institute of Experimental Physics, Faculty of Physics, University of Warsaw, Warsaw, Poland.
Department of Bacterial Genetics, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw, Poland.
ORCID: 0000-0003-3850-7598

Weronika Maksymiuk (W)

Division of Biophysics, Institute of Experimental Physics, Faculty of Physics, University of Warsaw, Warsaw, Poland.
ORCID: 0009-0009-6146-630X

Marta Narczyk (M)

Division of Biophysics, Institute of Experimental Physics, Faculty of Physics, University of Warsaw, Warsaw, Poland.
ORCID: 0000-0002-7844-7262

Ante Bubić (A)

Division of Physical Chemistry, Ruđer Bošković Institute, Zagreb, Croatia.
ORCID: 0000-0003-4548-9455

Ivana Leščić Ašler (IL)

Division of Physical Chemistry, Ruđer Bošković Institute, Zagreb, Croatia.
ORCID: 0000-0002-0826-7493

Paweł Krzyżek (P)

Department of Microbiology, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland.
ORCID: 0000-0002-3117-8894

Grażyna Gościniak (G)

Department of Microbiology, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland.
ORCID: 0000-0001-6597-9609

Elżbieta Katarzyna Jagusztyn-Krynicka (EK)

Department of Bacterial Genetics, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw, Poland.
ORCID: 0000-0003-0484-9290

Agnieszka Bzowska (A)

Division of Biophysics, Institute of Experimental Physics, Faculty of Physics, University of Warsaw, Warsaw, Poland.
ORCID: 0000-0002-3976-429X

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male

Management of the infected total elbow arthroplasty.

Joaquin Sanchez-Sotelo
1.00
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents

Mathematical modeling of vancomycin release from Poly-L-Lactic Acid-Coated implants.

Papon Thamvasupong, Kwanchanok Viravaidya-Pasuwat
1.00
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Mouse α-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases.

Arpine Sokratian, Ye Zhou, Meltem Tatli et al.
1.00
alpha-Synuclein Humans Animals Mice Lewy Body Disease

Classifications MeSH

questionsmedicales.fr › Bactéries › Proteobacteria › Epsilonproteobacteria › Campylobacterales › Helicobacteraceae › Helicobacter › Helicobacter pylori › Vitamin B6 inhibits activity of
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Vitamin B6 inhibits activity of
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Vitamin B6 inhibits activity of
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Pyridines › Picolines › Vitamine B6 › Vitamin B6 inhibits activity of
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Relation structure-activité › Vitamin B6 inhibits activity of
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Ligases › Carbon-nitrogen ligases › Adenylosuccinate synthase › Vitamin B6 inhibits activity of
questionsmedicales.fr › Phénomènes chimiques › Structure moléculaire › Vitamin B6 inhibits activity of
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes toxicologiques › Relation dose-effet des médicaments › Vitamin B6 inhibits activity of
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Mécanismes moléculaires de l'action pharmacologique › Antienzymes › Vitamin B6 inhibits activity of
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Résistance bactérienne aux médicaments › Vitamin B6 inhibits activity of
questionsmedicales.fr › Enzymes et coenzymes › Coenzymes › Phosphate de pyridoxal › Vitamin B6 inhibits activity of
questionsmedicales.fr › Techniques d'investigation › Modèles théoriques › Modèles moléculaires › Vitamin B6 inhibits activity of